Paper36077366
Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis.
Vliora M and 6 others. Int J Mol Sci, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis. Papers, record 36077366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36077366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibronectins | Major topic |
| Neoplasms | Major topic |
| Cytokines | |
| Exercise | |
| Humans | |
| Transcription Factors |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23664146 | Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. | Metabolism | 2013 | https://conductscience.org/library/papers/23664146 | PubMed |
| 2 | 33899538 | Role of myokines and osteokines in cancer cachexia. | Exp Biol Med (Maywood) | 2021 | https://conductscience.org/library/papers/33899538 | PubMed |
| 3 | 32554846 | Serum betatrophin and irisin levels in hepatocellular carcinoma. | J Physiol Pharmacol | 2020 | https://conductscience.org/library/papers/32554846 | PubMed |
| 4 | 27590717 | Serum levels of the adipomyokine irisin in patients with chronic kidney disease. | Nefrologia | 2016 | https://conductscience.org/library/papers/27590717 | PubMed |
| 5 | 27986567 | Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/27986567 | PubMed |
| 6 | 26963139 | Irisin immunohistochemistry in gastrointestinal system cancers. | Biotech Histochem | 2016 | https://conductscience.org/library/papers/26963139 | PubMed |
| 7 | 35016977 | Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes. | Biochim Biophys Acta Gen Subj | 2022 | https://conductscience.org/library/papers/35016977 | PubMed |
| 8 | 33112539 | Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study. | Asian Pac J Cancer Prev | 2020 | https://conductscience.org/library/papers/33112539 | PubMed |
| 9 | 28012856 | Increased FNDC5/Irisin expression in human hepatocellular carcinoma. | Peptides | 2017 | https://conductscience.org/library/papers/28012856 | PubMed |
| 10 | 29048621 | Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway. | Oncol Rep | 2017 | https://conductscience.org/library/papers/29048621 | PubMed |
| 11 | 35408891 | Expression of Irisin/FNDC5 in Breast Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35408891 | PubMed |
| 12 | 22237023 | A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. | Nature | 2012 | https://conductscience.org/library/papers/22237023 | PubMed |
| 13 | 29127759 | Is irisin the new player in exercise-induced adaptations or not? A 2017 update. | Clin Chem Lab Med | 2018 | https://conductscience.org/library/papers/29127759 | PubMed |
| 14 | 34807348 | Serum irisin is a novel biomarker for bladder cancer detection. | Int Urol Nephrol | 2022 | https://conductscience.org/library/papers/34807348 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 32469121 | Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. | FASEB J | 2020 | https://conductscience.org/library/papers/32469121 | PubMed |
| 17 | 30896263 | Immunostaining characteristics of irisin in benign and malignant renal cancers. | Biotech Histochem | 2019 | https://conductscience.org/library/papers/30896263 | PubMed |
| 18 | 32353410 | FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1. | Cell Signal | 2020 | https://conductscience.org/library/papers/32353410 | PubMed |
| 19 | 28867187 | Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28867187 | PubMed |
| 20 | 27256459 | Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer. | QJM | 2016 | https://conductscience.org/library/papers/27256459 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942453 | Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942453 | PubMed |
| 41480347 | The role of depression in the progression of tumor cell inflammation and the potential regulatory mechanisms of aerobic exercise: a narrative review from molecular and cellular perspectives. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41480347 | PubMed |
| 40859977 | Irisin's Dual Role in Malignant Tumors and Its Potential as a Biomarker and Therapeutic Target. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40859977 | PubMed |
| 39769243 | Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769243 | PubMed |
| 39505986 | FNDC5 affects invasion and migration of oral cancer by inhibiting PI3K/Akt/Snail signaling pathway. | Sci Rep | 2024 | https://conductscience.org/library/papers/39505986 | PubMed |
| 38540711 | Alterations of the Adipo-Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540711 | PubMed |
| 37728785 | The relationship between sarcopenia and serum irisin and TNF-α levels in newly diagnosed cancer patients. | Support Care Cancer | 2023 | https://conductscience.org/library/papers/37728785 | PubMed |
| 37239973 | The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239973 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| FNDC5 | 252995 | PubTator's text mining | https://conductscience.org/library/genes/252995 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| UCP1 | 7350 | PubTator's text mining | https://conductscience.org/library/genes/7350 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36077366
GET https://conductscience.org/api/papers/v1/36077366/references?page=2